2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk

The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

Saved in:
Bibliographic Details
Main Authors: Francois Mach, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, Lina Badimon, M. John Chapman, Guy G. De Backer, Victoria Delgado, Brian A. Ference, Ian M. Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R. Pedersen, Gabriele Riccardi, Dimitrios J. Richter, Marc S. Sabatine, Marja-Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2020-06-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/3826
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849249844370079744
author Francois Mach
Colin Baigent
Alberico L. Catapano
Konstantinos C. Koskinas
Manuela Casula
Lina Badimon
M. John Chapman
Guy G. De Backer
Victoria Delgado
Brian A. Ference
Ian M. Graham
Alison Halliday
Ulf Landmesser
Borislava Mihaylova
Terje R. Pedersen
Gabriele Riccardi
Dimitrios J. Richter
Marc S. Sabatine
Marja-Riitta Taskinen
Lale Tokgozoglu
Olov Wiklund
author_facet Francois Mach
Colin Baigent
Alberico L. Catapano
Konstantinos C. Koskinas
Manuela Casula
Lina Badimon
M. John Chapman
Guy G. De Backer
Victoria Delgado
Brian A. Ference
Ian M. Graham
Alison Halliday
Ulf Landmesser
Borislava Mihaylova
Terje R. Pedersen
Gabriele Riccardi
Dimitrios J. Richter
Marc S. Sabatine
Marja-Riitta Taskinen
Lale Tokgozoglu
Olov Wiklund
author_sort Francois Mach
collection DOAJ
description The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
format Article
id doaj-art-85da4c90ec0e40e594dfee9db7ef0e09
institution Kabale University
issn 1560-4071
2618-7620
language Russian
publishDate 2020-06-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-85da4c90ec0e40e594dfee9db7ef0e092025-08-20T03:57:26Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202020-06-0125510.15829/1560-4071-2020-382629022019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular riskFrancois Mach0Colin Baigent1Alberico L. Catapano2Konstantinos C. KoskinasManuela CasulaLina BadimonM. John ChapmanGuy G. De BackerVictoria DelgadoBrian A. FerenceIan M. GrahamAlison HallidayUlf LandmesserBorislava MihaylovaTerje R. PedersenGabriele RiccardiDimitrios J. RichterMarc S. SabatineMarja-Riitta TaskinenLale TokgozogluOlov WiklundGeneva University HospitalUniversity of OxfordUniversity of MilanThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)https://russjcardiol.elpub.ru/jour/article/view/3826guidelinesdyslipidaemiascholesteroltriglycerideslow-density lipoproteinshigh-density lipoproteinsapolipoprotein blipoprotein(a)lipoprotein remnantstotal cardiovascular risktreatment(lifestyle)treatment (drugs)treatment
spellingShingle Francois Mach
Colin Baigent
Alberico L. Catapano
Konstantinos C. Koskinas
Manuela Casula
Lina Badimon
M. John Chapman
Guy G. De Backer
Victoria Delgado
Brian A. Ference
Ian M. Graham
Alison Halliday
Ulf Landmesser
Borislava Mihaylova
Terje R. Pedersen
Gabriele Riccardi
Dimitrios J. Richter
Marc S. Sabatine
Marja-Riitta Taskinen
Lale Tokgozoglu
Olov Wiklund
2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
Российский кардиологический журнал
guidelines
dyslipidaemias
cholesterol
triglycerides
low-density lipoproteins
high-density lipoproteins
apolipoprotein b
lipoprotein(a)
lipoprotein remnants
total cardiovascular risk
treatment
(lifestyle)
treatment (drugs)
treatment
title 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
title_full 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
title_fullStr 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
title_full_unstemmed 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
title_short 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
title_sort 2019 esc eas guidelines for themanagement of dyslipidaemias lipid modification to reduce cardiovascular risk
topic guidelines
dyslipidaemias
cholesterol
triglycerides
low-density lipoproteins
high-density lipoproteins
apolipoprotein b
lipoprotein(a)
lipoprotein remnants
total cardiovascular risk
treatment
(lifestyle)
treatment (drugs)
treatment
url https://russjcardiol.elpub.ru/jour/article/view/3826
work_keys_str_mv AT francoismach 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT colinbaigent 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT albericolcatapano 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT konstantinosckoskinas 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT manuelacasula 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT linabadimon 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT mjohnchapman 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT guygdebacker 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT victoriadelgado 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT brianaference 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT ianmgraham 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT alisonhalliday 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT ulflandmesser 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT borislavamihaylova 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT terjerpedersen 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT gabrielericcardi 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT dimitriosjrichter 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT marcssabatine 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT marjariittataskinen 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT laletokgozoglu 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk
AT olovwiklund 2019esceasguidelinesforthemanagementofdyslipidaemiaslipidmodificationtoreducecardiovascularrisk